Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07166237

Group Cognitive Behavioural Therapy for Paternal Perinatal Depression

The purpose of this pilot randomized controlled trial is to assess the feasibility of offering a 9-week group cognitive behavioural therapy (CBT; a type of talking therapy) led by a psychiatrist and public health nurse to fathers and non-birthing parents who identify as fathers or fathers-to-be (have a partner who is expecting) with perinatal depression. Fathers or fathers-to-be living in Ontario who have depression symptoms while their partner has been pregnant and/or during the first 18 months of their child's life will be assigned with a 50/50 chance (like flipping a coin) to receive online group CBT in addition to usual care, or to receive usual care only.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

McMaster University

Hamilton, Ontario, L8S 4L8, Canada

About this study

This study will involve a pilot randomized controlled trial (RCT) to determine the feasibility of the intervention and study protocol for assessing if a 9-week group CBT intervention added to treatment as usual (TAU) can improve paternal perinatal depression symptoms more than TAU alone. The primary objective is to assess feasibility of the intervention including recruitment, completion of study measures, retention, and participant satisfaction/acceptability of the intervention. The secondary objective of the RCT is to estimate treatment effects on depressive symptoms to guide the conduct of a future full-scale RCT of the intervention. Estimate of treatment effect will serve as a primary outcome measure in a later full-scale RCT.

Forty-eight participants will be assigned in a 1:1 ratio to the experimental or control group. Participants in both groups will complete online questionnaires and structured telephone interviews at baseline (T1), 9 weeks later (T2 - immediately post-intervention in the experimental group) and 6 months post-enrollment (T3). Those assigned to receive the 9-week CBT group will also be asked questions about their satisfaction with the program and recommendations for improvement.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Non-birthing individuals identifying as fathers-to-be (i.e., have a pregnant partner) or fathers with an infant <18 months at recruitment, be fluent in written/spoken English, have an EPDS score ≥9 and live in Ontario

Exclusion criteria

  • Free of bipolar, psychotic, borderline personality and current substance use disorders

Treatment and study plan

Cognitive Behavioral Therapy for Paternal Perinatal Depression

Behavioral

Cognitive Behavioral Therapy (CBT) is a type of psychotherapy (talk therapy). The weekly group sessions will be two hours long and take place once a week for 9 consecutive weeks. The first hour of the session will involve teaching and practice of CBT skills, followed by one hour of unstructured discussion around topics relevant to participants with paternal perinatal depression. Each group will be delivered online via Zoom and guided by our intervention manual.

Primary outcomes

  1. Number of participants recruited in recruitment period

    Time frame: 6 months

    Recruit and randomize 48 participants (over two groups; 24 experimental, 24 control) in six months

  2. Number of participants who complete all data collection procedures

    Time frame: 6 months

    75% of participants complete all three questionnaires and structured interviews

  3. Number of participants who complete study (retention)

    Time frame: 6 months

    75% of participants remain in study until completion

  4. Number of participants who complete the intervention (adherence)

    Time frame: 6 months

    80% of participants in treatment group complete the intervention

Secondary outcomes

  1. Estimate treatment effect - Edinburgh Postnatal Depression Scale (EPDS)

    Time frame: 9 weeks

    Perinatal depression (PND) is best conceptualized as a continuous construct with its impact operating across a continuum of severity, and so a continuous measure of PND (EPDS) is our primary outcome. In keeping with most PND RCTs, our primary effectiveness time point is immediately post-treatment (T2). We will also assess the durability of intervention effects at three months post-T2 (T3). The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item gold standard measure of PND. Total scores range from 0-30 with higher scores indicating worse depressive symptoms. A score of ≥10 is consistent with possible PND, ≥13 is consistent with probable PND and changes in scores >4 are accepted as being indicative of clinically significant change.

Other outcomes

  1. Estimate treatment effect - Edinburgh Postnatal Depression Scale (EPDS)

    Time frame: 6 months

    Perinatal depression (PND) is best conceptualized as a continuous construct with its impact operating across a continuum of severity, and so a continuous measure of PND (EPDS) is our primary outcome. In keeping with most PND RCTs, our primary effectiveness time point is immediately post-treatment (T2). We will also assess the durability of intervention effects at three months post-T2 (T3). The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item gold standard measure of PND. Total scores range from 0-30 with higher scores indicating worse depressive symptoms. A score of ≥10 is consistent with possible PND, ≥13 is consistent with probable PND and changes in scores >4 are accepted as being indicative of clinically significant change.

  2. Major Depressive Disorder

    Time frame: 9 weeks

    A structured psychiatric interview will assess current psychiatric syndromes in participants. The Diagnostic Assessment Research Tool (DART) will be conducted at baseline, T2 and T3 to assess change in psychiatric symptoms over the study period.

  3. Major Depressive Disorder Module

    Time frame: 6 months

    A structured psychiatric interview will assess current psychiatric syndromes in participants. The Diagnostic Assessment Research Tool (DART) will be conducted at baseline, T2 and T3 to assess change in psychiatric symptoms over the study period.

  4. General Anxiety Disorder (GAD-7)

    Time frame: 9 weeks

    A reliable and valid 7-item self-report scale that assesses the symptoms of generalized anxiety disorder, the most common comorbidity of PND. A cutoff of ≥10 defines clinically important levels of anxiety symptoms and changes in scores >4 are accepted as being indicative of clinically significant change.

  5. General Anxiety Disorder (GAD-7)

    Time frame: 6 months

    A reliable and valid 7-item self-report scale that assesses the symptoms of generalized anxiety disorder, the most common comorbidity of PND. A cutoff of ≥10 defines clinically important levels of anxiety symptoms and changes in scores >4 are accepted as being indicative of clinically significant change.

  6. Parenting Stress Index - Short Form

    Time frame: 9 weeks

    The Parenting Stress Index (Short Form) is a 36-item parent self-report measure that identifies potentially dysfunctional parent-child systems on three subscales: parental distress, parent-child dysfunctional interaction, and difficult child. The measure also produces a total score that is an indication of overall level of stress a person is feeling in their role as a parent. Higher scores indicate higher levels of stress.

  7. Parenting Stress Index - Short Form

    Time frame: 6 months

    The Parenting Stress Index (Short Form) is a 36-item parent self-report measure that identifies potentially dysfunctional parent-child systems on three subscales: parental distress, parent-child dysfunctional interaction, and difficult child. The measure also produces a total score that is an indication of overall level of stress a person is feeling in their role as a parent. Higher scores indicate higher levels of stress.

  8. Multidimensional Scale of Perceived Social Support (MSPSS)

    Time frame: 9 weeks

    A 12-item scale designed to measure perceived social support from three sources: (1) family, (2) friends and (3) significant other. Items are scored on a 7-point scale, and total scores range from 12-84 with higher scores indicating a higher level of perceived social support. A score of 12-35 indicates low perceived social support, 36-60 indicates medium perceived social support and 61-84 indicates high perceived social support.

  9. Multidimensional Scale of Perceived Social Support (MSPSS)

    Time frame: 6 months

    A 12-item scale designed to measure perceived social support from three sources: (1) family, (2) friends and (3) significant other. Items are scored on a 7-point scale, and total scores range from 12-84 with higher scores indicating a higher level of perceived social support. A score of 12-35 indicates low perceived social support, 36-60 indicates medium perceived social support and 61-84 indicates high perceived social support.

  10. Dyadic Adjustment Scale (DAS)

    Time frame: 9 weeks

    The Dyadic Adjustment Scale (DAS) will be used to measure an individual's feelings about their relationship with an intimate partner. The scale contains 32-item with items scored on 2-, 5-,6-, or 7-point scales. The DAS contains four subscales: dyadic consensus, dyadic satisfaction, dyadic cohesion, and affective expression. Total scale scores were used in this study, with higher scores indicating greater relationship satisfaction.

  11. Dyadic Adjustment Scale (DAS)

    Time frame: 6 months

    The Dyadic Adjustment Scale (DAS) will be used to measure an individual's feelings about their relationship with an intimate partner. The scale contains 32-item with items scored on 2-, 5-,6-, or 7-point scales. The DAS contains four subscales: dyadic consensus, dyadic satisfaction, dyadic cohesion, and affective expression. Total scale scores were used in this study, with higher scores indicating greater relationship satisfaction.

  12. Postpartum Bonding Questionnaire (PBQ)

    Time frame: 9 weeks

    The Postpartum Bonding Questionnaire (PBQ) is a 25-item parent-report measure that assesses four aspects of father-infant relations: (1) bonding, (2) rejection and anger towards the infant, (3) infant-focused anxiety and (4) incipient abuse. Subscales 1-3 will be explored as a continuous outcome using subscale total score. Each item is scored on a scale of 0-5, with higher scores suggestive of more problems. Father-infant bonding will be measured as a continuous and dichotomous outcome, using cut-off scores for each subscale indicating bonding disorders. Cutoff values of 12 for the bonding subscale, 17 for rejection and anger, and 10 for infant-focused anxiety have been proposed to define bonding disorders in each category.

  13. Postpartum Bonding Questionnaire (PBQ)

    Time frame: 6 months

    The Postpartum Bonding Questionnaire (PBQ) is a 25-item parent-report measure that assesses four aspects of father-infant relations: (1) bonding, (2) rejection and anger towards the infant, (3) infant-focused anxiety and (4) incipient abuse. Subscales 1-3 will be explored as a continuous outcome using subscale total score. Each item is scored on a scale of 0-5, with higher scores suggestive of more problems. Father-infant bonding will be measured as a continuous and dichotomous outcome, using cut-off scores for each subscale indicating bonding disorders. Cutoff values of 12 for the bonding subscale, 17 for rejection and anger, and 10 for infant-focused anxiety have been proposed to define bonding disorders in each category.

  14. Infant Behavior Questionnaire-Revised Very Short Form (IBQ-R VSF)

    Time frame: 9 weeks

    The Infant Behaviour Questionnaire-Revised (Very Short Form) (IBQR) is a parent-report measure of infant temperament. The IBQ-R (Very Short Form) consists of 37 items answered on a 7-point scale (1-7) and assesses 3 factors: Positive Affectivity/Surgency with 13 items, Negative Emotionality with 12 items, and Orienting/Regulatory Capacity with 12 items; higher scores indicate greater alignment with the domain.

  15. Infant Behavior Questionnaire-Revised Very Short Form (IBQ-R VSF)

    Time frame: 6 months

    The Infant Behaviour Questionnaire-Revised (Very Short Form) (IBQR) is a parent-report measure of infant temperament. The IBQ-R (Very Short Form) consists of 37 items answered on a 7-point scale (1-7) and assesses 3 factors: Positive Affectivity/Surgency with 13 items, Negative Emotionality with 12 items, and Orienting/Regulatory Capacity with 12 items; higher scores indicate greater alignment with the domain.

  16. Maternal Perinatal Depression - Edinburgh Postnatal Depression Scale (EPDS)

    Time frame: 9 weeks

    To assess maternal perinatal depression (PND), partners of fathers participating in the study will complete the EPDS. The EPDS is a 10-item gold standard measure of PND. Total scores range from 0-30 with higher scores indicating worse depressive symptoms. A score of ≥10 is consistent with possible PND, ≥13 is consistent with probable PND and changes in scores >4 are accepted as being indicative of clinically significant change.

  17. Maternal Perinatal Depression - Edinburgh Postnatal Depression Scale (EPDS)

    Time frame: 6 months

    To assess maternal perinatal depression (PND), partners of fathers participating in the study will complete the EPDS. The EPDS is a 10-item gold standard measure of PND. Total scores range from 0-30 with higher scores indicating worse depressive symptoms. A score of ≥10 is consistent with possible PND, ≥13 is consistent with probable PND and changes in scores >4 are accepted as being indicative of clinically significant change.

  18. Healthcare Resource Utilization

    Time frame: 9 weeks

    Healthcare resource utilization data will be collected using a questionnaire used in prior work and adapted for the postpartum period (based on the Canadian Community Health Survey and Service Use and Resources Form). Participants will provide information on all healthcare service and medication use from T1 to T3 from the perspective of the public health care payer.

  19. Healthcare Resource Utilization

    Time frame: 6 months

    Healthcare resource utilization data will be collected using a questionnaire used in prior work and adapted for the postpartum period (based on the Canadian Community Health Survey and Service Use and Resources Form). Participants will provide information on all healthcare service and medication use from T1 to T3 from the perspective of the public health care payer.

  20. Quality-Adjusted Life Year (QALY)

    Time frame: 9 weeks

    The EQ-5D-5L is a utility-based health-related quality of life instrument assessing five domains (mobility, self-care, usual activities, pain, depression/anxiety) and will be administered at T1-T3. Its validity in measuring the impact of depression is established. We will use its Canadian algorithm to convert responses to health utility. QALYs will be calculated by multiplying the health utility for the corresponding time period (i.e., area under the curve approach).

  21. Quality-Adjusted Life Year (QALY)

    Time frame: 6 months

    The EQ-5D-5L is a utility-based health-related quality of life instrument assessing five domains (mobility, self-care, usual activities, pain, depression/anxiety) and will be administered at T1-T3. Its validity in measuring the impact of depression is established. We will use its Canadian algorithm to convert responses to health utility. QALYs will be calculated by multiplying the health utility for the corresponding time period (i.e., area under the curve approach).

  22. Client Satisfaction Questionnaire (CSQ-8)

    Time frame: 9 weeks

    Intervention participants only. We will assess participant satisfaction with the intervention using the eight-item Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 consists of eight items assessing the level of satisfaction with the intervention on a 4-point Likert-type scale, as well as one open-ended question. Responses to the open-ended question will be analyzed using content analysis to inform acceptability of the intervention.

Sponsors and collaborators

Lead sponsor

McMaster University

Other

Registry information

Official study title

Group Cognitive Behavioural Therapy for Paternal Perinatal Depression: A Pilot Randomized Controlled Trial

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 10, 2025
Registry last updated
Jan 26, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.